NCT04541082 2025-12-18Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsJazz PharmaceuticalsPhase 1 Recruiting102 enrolled
NCT06553339 2024-08-14A Study of HS-10516 in Patients With VHL Syndrome Associated TumorsJiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1 Recruiting60 enrolled
NCT02110563 2024-07-11Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or LymphomaNovo Nordisk A/SPhase 1 Terminated50 enrolled
NCT02736565 2023-11-13Pbi-shRNAâ„¢ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's SarcomaGradalis, Inc.Phase 1 Completed7 enrolled
NCT02355535 2020-09-24Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1Vanquish Oncology, Inc.Phase 1 Completed48 enrolled
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled